Natixis’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,334
| Closed | -$2.14M | – | 1029 |
|
|
2025
Q1 | $2.14M | Sell |
35,334
-78,666
| -69% | -$4.76M | 0.01% | 397 |
|
|
2024
Q4 | $7.8M | Buy |
114,000
+104,250
| +1,069% | +$7.13M | 0.05% | 267 |
|
|
2024
Q3 | $701K | Buy |
+9,750
| New | +$701K | ﹤0.01% | 571 |
|
|
2024
Q1 | – | Sell |
-58,700
| Closed | -$6.43M | – | 1013 |
|
|
2023
Q4 | $6.43M | Buy |
58,700
+3,900
| +7% | +$427K | 0.05% | 260 |
|
|
2023
Q3 | $5.53M | Buy |
54,800
+34,858
| +175% | +$3.52M | 0.04% | 269 |
|
|
2023
Q2 | $2.71M | Buy |
+19,942
| New | +$2.71M | 0.02% | 368 |
|
|
2022
Q4 | – | Sell |
-102,750
| Closed | -$8.24M | – | 1055 |
|
|
2022
Q3 | $8.24M | Buy |
+102,750
| New | +$8.24M | 0.04% | 296 |
|
|
2017
Q4 | – | Sell |
-4,187
| Closed | -$220K | – | 891 |
|
|
2017
Q3 | $220K | Buy |
+4,187
| New | +$220K | ﹤0.01% | 1080 |
|